Teladoc Health has secured new partnerships with Walmart and the National Basketball Players Association, expanding its virtual care footprint, even as the stock was removed from several Russell growth benchmarks. The shares fell 4.7% to about $9.07 on the day of the Russell removal, but have returned 28.1% over the past 30 days and 72.8% over 90 days. One fair value estimate places the stock at $7.40, suggesting it is 22.6% overvalued, while another view highlights a price-to-sales ratio of 0.7 times versus an industry average of 2.6 times, implying potential for revaluation. The company continues to invest in cardiometabolic and integrated mental health programs to capture demand for digital chronic disease management.
Teladoc IncNew partnerships with Walmart and NBPA expand virtual care footprint, driving demand for services.
Walmart Inc.